| Z0000 |
An unannounced Medicare Organ Procurement Organization (OPO) Re-approval survey was conducted on site from 03/14/22 through 03/17/22. The entrance conference convened on 03/14/22 at 9:00 AM with the Interim Executive Director (IED), two Organ Clinical Supervisors, (OCS) a Quality Analyst (QA), and the Organ Quality Supervisor (OQS).
An exit conference was conducted on 03/17/22 at 3:00 PM and included the IED, an OCS, the Director of Donation Development (DDD), the Financial and Operational Supervisor (FOS), the Lead Surgical Coordinator (LSC), and the OQS.
This facility was found to be in substantial compliance with the Federal Conditions for Coverage (CfC) set forth in 42 CFR Part 486, Subpart G. The following standard deficiencies were cited.
Z182 §486.344(d)(2)(ii) and Z120 §486.326(a)(3).
|